Identifying Novel Actionable Targets in Colon Cancer

by Maria Grazia Cerrito, Emanuela Grassilli
Published 2021-05-01

p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors

by Emanuela Grassilli, Maria Grazia Cerrito, Sara Bonomo, Roberto Giovannoni, Donatella Conconi, Marialuisa Lavitrano
Published 2021-06-01

GSK3A is redundant with GSK3B in modulating drug resistance and chemotherapy-induced necroptosis.

by Emanuela Grassilli, Leonarda Ianzano, Sara Bonomo, Carola Missaglia, Maria Grazia Cerrito, Roberto Giovannoni, Laura Masiero, Marialuisa Lavitrano
Published 2014-01-01

Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype

by Luca Sala, Giovanni Cirillo, Gabriele Riva, Gabriele Romano, Carlo Giussani, Annamaria Cialdella, Antonio Todisco, Assunta Virtuoso, Maria Grazia Cerrito, Angela Bentivegna, Emanuela Grassilli, Antonio Ardizzoia, Emanuela Bonoldi, Roberto Giovannoni, Michele Papa, Marialuisa Lavitrano
Published 2019-01-01

Role of Bruton’s Tyrosine Kinase in Stage III Colorectal Cancer

by Debora Basile, Lorenzo Gerratana, Angela Buonadonna, Silvio Ken Garattini, Tiziana Perin, Emanuela Grassilli, Gianmaria Miolo, Maria Grazia Cerrito, Claudio Belluco, Giulio Bertola, Antonino De Paoli, Renato Cannizzaro, Marialuisa Lavitrano, Fabio Puglisi, Vincenzo Canzonieri
Published 2019-06-01

p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma

by Federica Giordano, Valentina Vaira, Diego Cortinovis, Sara Bonomo, Joyce Goedmakers, Federica Brena, Annamaria Cialdella, Leonarda Ianzano, Irene Forno, Maria Grazia Cerrito, Roberto Giovannoni, Gian Luca Ferri, Ennio Tasciotti, Silve Vicent, Francesco Damarco, Silvano Bosari, Marialuisa Lavitrano, Emanuela Grassilli
Published 2019-06-01